Indication
Sensitization
2 clinical trials
2 products
Clinical trial
Non-Randomized, Single-Center Pilot Trial Assessing The Safety/Efficacy Of Targeting Peripheral And Central Humoral Alloimmune Memory With Daratumumab And With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney TransplantationStatus: Recruiting, Estimated PCD: 2024-12-01
Product
belataceptClinical trial
Hypersensitivity Pneumonitis of Domestic Origin: Investigation of the Microorganisms Involved and Improvement of Serological Diagnosis.Status: Not yet recruiting, Estimated PCD: 2026-03-01
Product
Blood Sample